Candidate Urine Peptide Biomarkers for IgA Nephropathy: Where Are We Now?

Early detection, prognosis, and management of IgA nephropathy (IgAN) remain a challenge. Histological examination of renal tissue still comprises the only way to confirm an IgAN diagnosis. It is of great importance to establish noninvasive diagnostic, prognostic, and predictive biomarkers that would...

Descripción completa

Detalles Bibliográficos
Autores principales: Marek-Bukowiec, Karolina, Konieczny, Andrzej, Ratajczyk, Krzysztof, Witkiewicz, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827886/
https://www.ncbi.nlm.nih.gov/pubmed/29606986
http://dx.doi.org/10.1155/2018/5205831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827886/
https://www.ncbi.nlm.nih.gov/pubmed/29606986
http://dx.doi.org/10.1155/2018/5205831

Ejemplares similares